DRAGONI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 2.680
AS - Asia 2.284
EU - Europa 2.036
SA - Sud America 241
AF - Africa 54
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.318
Nazione #
US - Stati Uniti d'America 2.585
RU - Federazione Russa 740
CN - Cina 647
SG - Singapore 643
IT - Italia 606
HK - Hong Kong 200
VN - Vietnam 194
KR - Corea 185
BR - Brasile 177
BD - Bangladesh 149
PL - Polonia 103
FR - Francia 101
IE - Irlanda 98
DE - Germania 88
SE - Svezia 81
FI - Finlandia 72
JP - Giappone 68
IN - India 64
CA - Canada 61
GB - Regno Unito 44
NL - Olanda 37
JO - Giordania 36
ID - Indonesia 29
AR - Argentina 25
AU - Australia 22
NG - Nigeria 17
MX - Messico 15
ES - Italia 14
BE - Belgio 13
CO - Colombia 10
PK - Pakistan 10
UY - Uruguay 10
UA - Ucraina 9
ZA - Sudafrica 9
IQ - Iraq 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BJ - Benin 6
CL - Cile 6
TR - Turchia 6
HN - Honduras 5
PE - Perù 5
PH - Filippine 5
RS - Serbia 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
OM - Oman 4
SA - Arabia Saudita 4
AT - Austria 3
AZ - Azerbaigian 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EC - Ecuador 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
NI - Nicaragua 2
PS - Palestinian Territory 2
TG - Togo 2
TH - Thailandia 2
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.315
Città #
Santa Clara 717
Singapore 501
Ashburn 422
Hefei 222
Seoul 179
Hong Kong 173
San Jose 151
Warsaw 102
Dublin 98
Milan 98
Ho Chi Minh City 84
Beijing 83
New York 77
Los Angeles 73
Council Bluffs 69
Florence 67
Tokyo 63
Lauterbourg 56
Munich 55
Rome 51
Moscow 45
Buffalo 43
Hanoi 43
Chandler 42
Dallas 37
Fairfield 37
Helsinki 36
Boardman 32
Kent 31
Altamura 26
Lawrence 24
Shanghai 23
Turku 22
Jakarta 21
Mumbai 20
Melbourne 19
Paris 19
Toronto 19
Woodbridge 18
Abuja 17
Cambridge 17
Da Nang 17
Naples 17
Orem 17
Seattle 17
Turin 17
Frankfurt am Main 16
São Paulo 16
West Jordan 16
London 15
The Dalles 15
Boston 14
Houston 14
Lappeenranta 14
Bologna 13
Chicago 13
Bengaluru 12
Montreal 12
Princeton 12
Wilmington 12
Atlanta 10
Bari 10
Chennai 10
Amman 9
Guangzhou 8
Yubileyny 8
Belo Horizonte 7
Brooklyn 7
Cagliari 7
Fontebuona 7
Haiphong 7
Tashkent 7
Charlotte 6
Cotonou 6
Genoa 6
Montevideo 6
Palermo 6
Phoenix 6
Pune 6
Rimini 6
Washington 6
Ann Arbor 5
Belgrade 5
Brasília 5
Buenos Aires 5
Johannesburg 5
Mexico City 5
Montelupo Fiorentino 5
Newark 5
San Diego 5
Almere Stad 4
Brussels 4
City of London 4
Corigliano Calabro 4
Dong Ket 4
Elk Grove Village 4
Falls Church 4
Figino 4
Hastings 4
Madrid 4
Totale 4.447
Nome #
NUCLEAR ORPHAN RECEPTOR COUP-TF2 INCREASED THE RESISTANCE TO ANIKOISIS AND THE METASTATIC POTENTIAL IN HEPATOCELLULAR CARCINOMA 265
Relationship between nutritional screening tools and glim in complicated IBD requiring surgery 226
Correlation of Ultrasound Scores with Endoscopic Activity in Crohn's Disease: A Prospective Exploratory Study 220
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives 211
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 210
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey 195
GLIM Criteria for Malnutrition in Surgical IBD Patients: A Pilot Study 193
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 191
Practical insights into chronic management of hepatic Wilson's disease 190
Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center 187
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 182
CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib 179
Effect of long-lasting nutritional prehabilitation on postoperative outcome in elective surgery for IBD 178
Metabolic disorders across hepatocellular carcinoma in Italy 172
Applicability of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to ulcerative colitis: a preliminary study 171
Is the age at surgery in Crohn's disease clinically relevant? Differences and peculiarities: a wide single centre experience after long-term follow-up 161
Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms 158
Non-small-bowel lesions identification by capsule endoscopy: A single centre retrospective study 157
Nutritional adequacy in surgical IBD patients 157
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 155
Main factors influencing long-term outcomes of liver transplantation in 2022 153
MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing? 151
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 151
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease 150
Branch duct-intraductal papillary mucinous neoplasms (BD-IPMNs): an MRI-based radiomic model to determine the malignant degeneration potential 149
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 148
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study 146
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 145
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice 143
OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVELOPMENT IN MICE 136
Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centers 134
Time-varying mHAP III is the most accurate predictor of survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 133
Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach 131
Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches? 130
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 121
Gastric Antral Vascular Ectasia (GAVE) a case report, review of the literature and update of techniques 121
Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice 117
Schistosomiasis in non-endemic areas: Italian consensus recommendations for screening, diagnosis and management by the Italian Society of Tropical Medicine and Global Health (SIMET), endorsed by the Committee for the Study of Parasitology of the Italian Association of Clinical Microbiologists (CoSP-AMCLI), the Italian Society of Parasitology (SoIPa), the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE), the Italian Society of Gynaecology and Obstetrics (SIGO), the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV), the Italian Society of General Medicine and Primary Care (SIMG), the Italian Society of Infectious and Tropical Diseases (SIMIT), the Italian Society of Pediatrics (SIP), the Italian Society of Paediatric Infectious Diseases (SITIP), the Italian Society of Urology (SIU) 108
The Impact of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation on the Early Development of Intestinal Fibrosis in Crohn’s Disease 101
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 65
The use of International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) in patients with ulcerative colitis: applicability and comparison with other ultrasound scores 60
P0925 Risk of postoperative Crohn’s disease recurrence in patients smoking e-cigarettes and heat-not-burn tobacco products: a multicenter retrospective study 47
Fatigue and circadian rhythm in non-cirrhotic primary biliary cholangitis: An exploratory comparison with primary sclerosing cholangitis and healthy controls 44
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series 40
Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn's disease 40
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study 39
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class 39
53: THE IMPACT OF E-CIGARETTES AND HEAT-NOT-BURN TOBACCO ON CROHN’S DISEASE POSTOPERATIVE RECURRENCE: A MULTICENTER RETROSPECTIVE STUDY 38
Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey 37
Redefining remission targets in inflammatory bowel disease: The rise of ultrasound remission 36
Bowel Damage and Disability in Crohn's Disease: Is it Really Two Birds with One Stone? 34
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 33
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How 32
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease 32
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey 28
The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis? 27
Fibroblast Heterogeneity in Inflammatory Bowel Disease 27
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study 26
Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study 25
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series 25
The Impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study 23
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 23
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 23
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series 22
European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation 21
Systematic Review of Available Intestinal Ultrasound Scores for Inflammatory Bowel Disease and Update on Validation Studies 20
P1156 Fidaxomicin for Clostridiodes difficile infection in inflammatory bowel disease: a multicenter retrospective cohort study 20
Multidisciplinary Perinatal Care in IBD 20
Salivary oxidative stress persists in inflammatory bowel disease regardless of biological treatment response 19
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study 18
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study] 18
Sa1937: FIDAXOMICIN FOR CLOSTRIDIODES DIFFICILE INFECTION IN INFLAMMATORY BOWEL DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY 17
Results of the Eighth Scientific Workshop of ECCO: Diagnosing Postoperative Recurrence of Crohn's Disease After an Ileocolonic Resection With Ileocolonic Anastomosis 16
Golimumab in inflammatory bowel diseases: present and future scenarios 14
Response to Wei-Zhen Tang et al 13
Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in Children: A Multicenter Prospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition 7
Correction to: CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib 6
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care 5
Totale 7.405
Categoria #
all - tutte 22.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202287 2 6 12 1 2 8 0 5 7 7 12 25
2022/2023389 18 58 16 7 30 72 57 25 55 23 24 4
2023/2024372 8 26 31 18 27 49 22 71 10 57 35 18
2024/20252.250 79 201 114 329 613 296 31 98 120 69 116 184
2025/20263.884 384 430 397 235 266 156 456 202 348 299 317 394
2026/2027186 186 0 0 0 0 0 0 0 0 0 0 0
Totale 7.405